Cite

HARVARD Citation

    Gandullo‐Sánchez, L. et al. (2020). HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies. EMBO molecular medicine. 12 (5), p. n/a. [Online]. 
  
Back to record